Verluma

Verluma

Nofetumomab Imaging An agent that detects a protein on the surface of most small cell lung CAs; it may be used to diagnose biopsy-confirmed tumors. See Small cell lung cancer.
References in periodicals archive ?
His principal achievements include establishing strategic relationships with two pharmaceutical companies, DuPont Merck and Boehringer Ingleheim, relating to the manufacture and marketing of NeoRx's Verluma Cancer Imaging Product.
A Product License and Establishment License Application for Verluma, a small cell lung cancer imaging agent developed by NeoRx, is in late stage review at the Food and Drug Administration.